Patellar Tendinopathy - The Effect of Load Magnitude in Exercise-based Treatment

March 7, 2022 updated by: Anne-Sofie Agergaard, Bispebjerg Hospital

Treatment of Patellar Tendinopathy; Influence of Load Magnitude on Clinical Outcome, Tendon Structure and Function

The purpose of this project is to investigate if the magnitude of a loading based 12 weeks rehabilitation regime for patellar tendinopathy influence the clinical outcome, tendon structure and function.

The investigators hypothesize that a greater magnitude (90% of 1RM) of loading will yield a more positive clinical outcome, tendon structure and function in patients with patellar tendinopathy compared to a lower magnitude of loading (55% of 1 RM) when total exercise volume is equal in both groups.

Study Overview

Detailed Description

Randomized controlled intervention study with one year follow-up

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2400
        • Department of Physical and Occupational Therapy / Institute of Sports Medicine Copenhagen, Bispebjerg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Uni- or bilateral patellar tendinopathy
  • Symptoms > 3 months
  • Ultrasonographical tendon swelling
  • Ultrasonographical hypo-echoic area with doppler
  • BMI 18.5-30

Exclusion Criteria:

  • Patellar tendinopathy > 12 month
  • Previous knee surgery
  • Confounding diagnosis to the knee joint
  • Diabetes or arthritis
  • Previous corticosteroid injection for patellar tendinopathy
  • Smoking
  • Being elite volleyball players

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Heavy slow resistance group
Heavy slow resistance training. Three times weekly for 12 weeks.
Resistance training for knee extensors. The exercise will be performed at 90% of 1 RM and slowly (6 s/repetition).
Experimental: Moderate slow resistance group
Moderate slow resistance training. Three times weekly for 12 weeks.
Resistance training for knee extensors. The exercise will be performed at 55% of 1 RM and slowly (6 s/repetition).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Victorian Institute of Sports Assessment - Patella Questionnaire (VISA-P) at 12 wks
Time Frame: 0-12 wks
Patient reported outcome regarding symptoms, function and the ability to participate in sports
0-12 wks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Victorian Institute of Sports Assessment - Patella Questionnaire (VISA-P)
Time Frame: 0 and 6 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Patient reported outcome regarding symptoms, function and the ability to
0 and 6 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Pain rating on numeric rating scale (NRS) and activity level of sporting activities (h/wk)
Time Frame: 0,6,12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Questionnaire
0,6,12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Tendon thickness and Doppler activity
Time Frame: 0,6,12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Measured by ultrasound
0,6,12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Single-leg decline squat (SLDS) test
Time Frame: 0,6, 12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
A reliable patellar tendon pain provocation test, will be used to assess pain during function
0,6, 12 wks + 1 yr follow up + Long-term follow-up (2-4 yr)
Jump test
Time Frame: 0 and 12 wks
Squat jump and Counter movement Jump will be used to assess patellar tendinopathy caused functional deficits on the injured site compared with the non-injured site
0 and 12 wks
Mechanical properties
Time Frame: 0 and 12 wks
Synchronized tendon elongation with the use of ultrasonography along with force measures, will be used during voluntary contractions to determine mechanical properties
0 and 12 wks
Muscle strength
Time Frame: 0 and 12 wks
Maximal muscle strength of the knee extensors is obtained during a maximal voluntary contractions
0 and 12 wks
Tendon dimensions and structure
Time Frame: 0 and 12 wks
Measured by MRI
0 and 12 wks
Treatment satisfaction
Time Frame: 12 wks + 1 yr follow-up + Long-term follow-up (2-4 yr)
Questionnaire
12 wks + 1 yr follow-up + Long-term follow-up (2-4 yr)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Peter Magnusson, Professor, Bispebjerg Hospital, University of Copenhagen
  • Principal Investigator: Anne-Sofie Agergaard, Phd.Student, Bispebjerg Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2017

Primary Completion (Actual)

June 25, 2019

Study Completion (Actual)

October 1, 2021

Study Registration Dates

First Submitted

March 17, 2017

First Submitted That Met QC Criteria

March 24, 2017

First Posted (Actual)

March 30, 2017

Study Record Updates

Last Update Posted (Actual)

March 8, 2022

Last Update Submitted That Met QC Criteria

March 7, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BBH131

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Jumper's Knee

Clinical Trials on Heavy slow resistance training

Subscribe